This is in profound contrast to the fibrillar tau lesions in AD, rather than those confined to GM, spreading from the hippocampal formation to extensive neocortical regions.6 Hence, the composition of tau isoforms and interactions of tau with Aβ and other nontau amyloidogenic protein species may determine localization of tau deposition and focal symptoms. The gene discussed is MAPT; the disease is Alzheimer disease.